EXHIBIT B AGREEMENT AND PLAN OF MERGER among INFORMAX, INC., INVITROGEN CORPORATION and BABCOCK, INC. Dated as of October 15, 2002Merger Agreement • December 2nd, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT AND PLAN OF MERGER (the “Agreement”), dated as of October 15, 2002 is entered into by and among INFORMAX, INC., a Delaware corporation (the “Company”), INVITROGEN CORPORATION, a Delaware corporation (“Parent”), and BABCOCK, INC., a Delaware corporation and a wholly-owned subsidiary of Parent (“Purchaser”).
EXHIBIT C Agreement Between Purchaser and Invitrogen Required by 13d-1(k)(1)(iii) Exhibit Required by Item 7 of Schedule 13D AGREEMENTAgreement Between Purchaser and Invitrogen Required by 13d-1(k)(1)(iii) • December 2nd, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances)
The undersigned persons hereby agree that reports on Schedule 13D, and any amendments thereto, including such reports made by or as part of a Tender Offer Statement on Schedule TO, may be filed in a single statement on behalf of all such persons, and further, each such person designates John D. Thompson as its agent and attorney-in-fact for the purpose of executing any and all such reports required to be made by it with the Securities and Exchange Commission.
